A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects
1. 系统已在2025-05-20 10:58:48对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s13318-025-00944-5
文献链接: https://link.springer.com/10.1007/s13318-025-00944-5
其他信息:
出版社: Springer Science and Business Media LLC
作者: Ying Wang; Yuanzhi Cheng; Yuhan Guo; Yang Fan; Renpeng Zhou; Qian Zhang; Ye Xu; Sheng Feng; Kai Shen; Wei Hu
全文下载地址: https://link.springer.com/content/pdf/10.1007/s13318-025-00944-5.pdf